We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.27%
AUM
$4.72B
AUM Growth
-$29.5K
Cap. Flow
-$108M
Cap. Flow %
-2.29%
Top 10 Hldgs %
8.96%
Holding
582
New
51
Increased
231
Reduced
239
Closed
47

Top Buys

Rank Stock Value
1
TEX icon
Terex
TEX
+$35.8M
2
RAL
Ralliant Corp
RAL
+$35.5M
3
ALGM icon
Allegro MicroSystems
ALGM
+$29.8M
4
MCB icon
Metropolitan Bank Holding Corp
MCB
+$18.7M
5
RXO icon
RXO
RXO
+$14.3M

Sector Composition

Rank Sector Weight
1 Industrials 20.13%
2 Healthcare 19.35%
3 Financials 19.32%
4 Technology 12.31%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIN icon
301
Trinity Capital
TRIN
$1.55B
$4.86M 0.1%
330,599
+10,561
+3% +$163K
LAD icon
302
Lithia Motors
LAD
$7.78B
$4.85M 0.1%
19,425
-438
-2% -$130K
DV icon
303
DoubleVerify
DV
$1.62B
$4.83M 0.1%
508,389
+12,507
+3% +$128K
SITM icon
304
SiTime
SITM
$16.6B
$4.81M 0.1%
13,920
-177
-1% -$65.1K
RRX icon
305
Regal Rexnord
RRX
$14.2B
$4.77M 0.1%
25,455
-21,647
-46% -$4.02M
COLB icon
306
Columbia Banking Systems
COLB
$8.81B
$4.74M 0.1%
172,812
+53,454
+45% +$1.55M
A icon
307
Agilent Technologies
A
$39.1B
$4.7M 0.1%
41,202
-4,039
-9% -$512K
SLP icon
308
Simulations Plus
SLP
$371M
$4.6M 0.1%
389,309
-9,593
-2% -$141K
RARE icon
309
Ultragenyx Pharmaceutical
RARE
$2.65B
$4.59M 0.1%
+219,291
New +$4.94M
SOPH icon
310
SOPHiA GENETICS
SOPH
$480M
$4.59M 0.1%
+927,800
New +$4.51M
CRMD icon
311
CorMedix
CRMD
$617M
$4.57M 0.1%
673,302
+15,197
+2% +$112K
DXCM icon
312
DexCom
DXCM
$27.6B
$4.56M 0.1%
72,687
+143
+0.2% +$9.96K
ASUR icon
313
Asure Software
ASUR
$220M
$4.54M 0.1%
528,059
+12,672
+2% +$112K
AEBI
314
Aebi Schmidt Holding AG
AEBI
$1.01B
$4.54M 0.1%
467,239
+11,152
+2% +$153K
CRD.A icon
315
Crawford & Co Class A
CRD.A
$536M
$4.53M 0.1%
454,688
+12,104
+3% +$127K
USCB icon
316
USCB Financial Holdings
USCB
$396M
$4.51M 0.1%
243,436
RYAN icon
317
Ryan Specialty Holdings
RYAN
$5.41B
$4.45M 0.09%
131,773
+12,697
+11% +$542K
DRS icon
318
Leonardo DRS
DRS
$12.8B
$4.41M 0.09%
99,152
-1,214
-1% -$51.2K
RDVT icon
319
Red Violet
RDVT
$859M
$4.41M 0.09%
127,321
+3,633
+3% +$160K
JBSS icon
320
John B. Sanfilippo & Son
JBSS
$949M
$4.34M 0.09%
54,765
+990
+2% +$76.2K
BVS icon
321
Bioventus
BVS
$799M
$4.34M 0.09%
474,971
+12,412
+3% +$104K
LXU icon
322
LSB Industries
LXU
$881M
$4.25M 0.09%
285,000
+7,645
+3% +$87.2K
NVT icon
323
nVent Electric
NVT
$24.5B
$4.17M 0.09%
+35,281
New +$4.01M
TBRG
324
DELISTED
TruBridge
TBRG
$4.16M 0.09%
283,839
+6,520
+2% +$124K
UNTY icon
325
Unity Bancorp
UNTY
$583M
$4.14M 0.09%
79,829
+1,091
+1% +$57.5K

Similar funds

Kennedy Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Kennedy Capital Management held 582 positions worth $4.72B, down 0% from $4.72B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Kennedy Capital Management's Q1 2026 filing shows 51 new, 231 increased, 239 reduced and 47 closed positions. Its largest new stake was Terex: 577,450 shares worth $34.1M. The largest sale was REV Group, an estimated $31.5M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Kennedy Capital Management's largest Q1 2026 buy was Terex: 577,450 shares worth $34.1M.
  • Kennedy Capital Management added most to Allegro MicroSystems in Q1 2026, an estimated $29.8M increase.
  • Kennedy Capital Management's biggest Q1 2026 reduction was MKS Inc, cutting an estimated $24.3M.
  • Kennedy Capital Management fully exited REV Group in Q1 2026, selling an estimated $31.5M.
  • Kennedy Capital Management's ten largest holdings make up 9% of its $4.72B portfolio in Q1 2026.
  • Kennedy Capital Management opened 51 new positions and closed 47 in Q1 2026.
  • Kennedy Capital Management's portfolio value fell 0% quarter-over-quarter to $4.72B.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.